Search
Clinician Ordering Portal
On-demand education
Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.
Nov 2006
J Mol Diagn 2006;8:567-73.
Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.
Diagn Pathol 2017;12(1):59.
Clinical performance and management outcomes with the DecisionDx-UM gene expression profile test in a prospective multicenter study.
Jun 2016
J Oncol 2016; doi:10.1155/2016/5325762.
Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling.
Mar 2020
Melanoma Manag 2020;7(1):MMT37.
PRAME as an independent biomarker for metastasis in uveal melanoma.
Mar 2016
Clin Cancer Res 2016;22(5):1234-42.
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Apr 2011
J Med Genet 2011;48:856-9.
Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes.
Jul 2016
JAMA Ophthalmol 2016;134:728-33.
Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
Aug 2014
Invest Ophthalmol Vis Sci 2014;55:5160-7.
Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations
Aug 2015
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
Jan 2013
Nat Genet 2013;45:133-5.